Journal Mobile Options
Table of Contents
Vol. 65, No. 3, 2000
Issue release date: 2000
Urol Int 2000;65:130–134

General State of Health and Psychological Well-Being in Patients after Surgery for Urological Malignant Neoplasms

Ficarra V. · Righetti R. · D’Amico A. · Pilloni S. · Balzarro M. · Schiavone D. · Malossini G. · Mobilio G.
Department of Urology, University of Verona, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To evaluate the general state of health and the psychological well-being in a group of 155 patients after surgery for urological malignant neoplasms. Materials and Methods: Surgery was performed in 55 patients for renal cell carcinoma, in 54 for invasive bladder carcinoma, in 30 for adenocarcinoma of the prostate, and in 16 for squamous penile carcinoma. All patients were invited to self-compile the General Health Questionnaire (GHQ) – 12 items according to Goldberg and the Hospital Anxiety and Depression Scale. Results were compared with those in a group of patients who underwent retropubic prostatectomy for benign prostatic hyperplasia. Results and Conclusion: The general state of health was significantly more impaired in neoplastic patients than in the control group. Levels of anxiety were significantly higher but depression levels were similar in both groups. As far as the type of tumor is concerned, patients who underwent radical cystectomy for bladder carcinoma and those treated with partial penectomy for squamous penile carcinoma showed a significant impairment of the general state of health compared with controls. Higher levels of anxiety were observed in patients who underwent ileal conduit after radical cystectomy, in those treated with radical prostatectomy for prostate cancer and in those who underwent partial penectomy. Significantly higher levels of depression than in the control group were observed only in patients with ileal conduit.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Ganz PA: Long-range effect of clinical trial interventions quality of life. Cancer 1994;74:2620.

    External Resources

  2. Kiebert GM: Quality of life as an outcome measure in cancer clinical trials. Eur Urol 1997;31(suppl 1):56.
  3. Goldberg D: Manual of General Health Questionnaire. Windsor, NFR Publishing Company, 1978.
  4. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–370.
  5. Bullinger M: Quality of life: Definition, conceptualization and applications: A methodologist’s view. Theor Surg 1991;6:143–148.
  6. Guyatt GH, Fenny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993;118:622–629.
  7. Litwin MS, Fine JT, Dorey F, Figlin RA, Belldegrun AS: Health related quality of life outcomes in patients treated for metastatic kidney cancer: A pilot study. J Urol 1997;157:1608–1612.

    External Resources

  8. Mansson A, Johnson G, Mansson W: Quality of life after cystectomy. Comparison between patients with conduit and those with continent caecal reservoir urinary diversion. Br J Urol 1988;62:240–245.
  9. Mansson A, Mansson W: When the bladder is gone: Quality of life following different types of urinary diversion. World J Urol 1999;17:211–218.
  10. Boyd SD, Feinberg SM, Skinner DG, Lieskovsky G, Baron D, Richardson J: Quality of life survey of urinary diversion patients: Comparison of ileal conduits versus continent Kock ileal reservoir. J Urol 1987;138:1386–1389.
  11. Gerharz EW, Weingartner K, Dopatka T, Kohl UN, Basler HD, Riedmiller HN: Quality of life after cystectomy and urinary diversion: Results of a retrospective interdisciplinary study. J Urol 1997;158:778–785.

    External Resources

  12. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al: Quality of Life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129–135.
  13. Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L: Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996;14:2258–2265.
  14. Lim AJ, Brandon AH, Fiedler J, Brickman AL, Boyer CI, Raub WA, et al: Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995;154:1420–1425.
  15. Herr HW: Quality of life of incontinent men after prostatectomy. J Urol 1994;151:652–654.
  16. Opyordsmoen S, Fossa SS: Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol 1994;74:652–657.
  17. Levi d’Ancona CA, Bottega NJ, Moraes C, Lavora N, Santos J, Netto NR: The quality of life after penectomy for penile carcinoma. Urology 1998;50:593–596.
  18. Ficarra V, Mofferdin A, D’Amico A, Zanon G, Schiavone D, Malossini G, Mobilio G: Comparaison de la qualité de vie des patients traités pour le cancer épidermoïde de la verge par chirurgie ou radiothérapie. Progr Urol 1999;9:715–720.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50